FMP
Medical Properties Trust, Inc.
MPW
NYSE
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
5.87 USD
0.05 (0.852%)
Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
543k
913.08M
436k
371.21M
35M
35.83M
36.68M
37.55M
38.44M
39.35M
Revenue %
-
168.05k
-99.95
85.04k
-90.57
2.37
2.37
2.37
2.37
Operating Cash Flow
-238.37M
538.97M
-495.74M
-260.38M
-142.77M
-22.29M
-22.82M
-23.36M
-23.92M
-24.48M
Operating Cash Flow %
-43.9k
59.03
-113.7k
-70.14
-407.93
-62.22
-62.22
-62.22
-62.22
Cap Ex
-18.36M
-81.7M
-37.19M
-11.97M
-1.9M
-15.59M
-15.96M
-16.34M
-16.73M
-17.12M
Cap Ex %
-3.38k
-8.95
-8.53k
-3.22
-5.43
-43.52
-43.52
-43.52
-43.52
Free Cash Flow
-256.72M
457.27M
-532.93M
-272.35M
-144.68M
-37.89M
-38.78M
-39.7M
-40.64M
-41.61M
Weighted Average Cost Of Capital
Price
42.12
Beta
Diluted Shares Outstanding
84.36M
Costof Debt
4.09
Tax Rate
After Tax Cost Of Debt
4.09
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
223.69M
Total Equity
3.55B
Total Capital
3.78B
Debt Weighting
5.92
Equity Weighting
94.08
Wacc
11.91
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
543k
913.08M
436k
371.21M
35M
35.83M
36.68M
37.55M
38.44M
39.35M
Operating Cash Flow
-238.37M
538.97M
-495.74M
-260.38M
-142.77M
-22.29M
-22.82M
-23.36M
-23.92M
-24.48M
Cap Ex
-18.36M
-81.7M
-37.19M
-11.97M
-1.9M
-15.59M
-15.96M
-16.34M
-16.73M
-17.12M
Free Cash Flow
-256.72M
457.27M
-532.93M
-272.35M
-144.68M
-37.89M
-38.78M
-39.7M
-40.64M
-41.61M
Wacc
11.91
11.91
11.91
11.91
11.91
Pv Lfcf
-33.85M
-30.97M
-28.33M
-25.91M
-23.7M
Sum Pv Lfcf
-142.76M
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
11.91
Free Cash Flow T1
-42.44M
Terminal Value
-428.08M
Present Terminal Value
-243.84M
Intrinsic Value
Enterprise Value
-386.6M
Net Debt
-74.56M
Equity Value
-312.03M
Diluted Shares Outstanding
84.36M
Equity Value Per Share
-3.7
Projected DCF
-3.7 12.384%
